Serum Institute of India buys Czech Republic’s Nanotherapeutics

This acquisition of the Czech Republic based company will add to SII group injectable Polio capacity, increasing it by 4 times to a total of 200 million doses by 2019

0
297
Download PDF

New Delhi: One of the largest vaccine manufacturer globally, the Serum Institute of India (SII), has acquired Czech biopharma company Nanotherapeutics.

Nanotherapeutics has manufacturing capabilities for biologic products that will provide the department of defence and US government with ability to rapidly respond to emerging disease threats and chemical, biologic, radiological and nuclear events.

This acquisition will add to SII group injectable Polio capacity, increasing it by 4 times to a total of 200 million doses by 2019, making SII the largest injectable non oral Polio vaccine manufacturer in the world. The plant at Bohumil, which is one hour off the Czech Republic capital Prague, is not functional now.

The media reports have quoted the deal at €72 million, however, there has been no official confirmation over the cost from the company.

Pune-based Serum institute is currently one of the largest manufacturers of MMR group of vaccines and Pentavalent group of vaccines in the world, present in 147 countries. The company plans to add around 200 employees in the next 2-3 years in Czech Republic.

This is the second overseas acquisition for the SII after it bought a plant during 2012 in Holland.

NO COMMENTS